乳酸和RNA修饰在瘤发生中的交叉声:机制和治疗含义
Shantong Liu1,2,3, Qianquan Ma4, Chong Zeng5
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Biomarker research
|August 27, 2025
概括
乳化是一种转化后修饰 (PTM),与癌症中的RNA修饰相互作用. 了解这种交叉通话为精确向癌症治疗提供了新的治疗策略.
科学领域:
- 生物化学
- 分子生物学
- 癌症研究
背景情况:
- 新出现的证据将乳化,一种后翻译性修饰 (PTM) 与瘤进展联系起来.
- 乳化和RNA修饰在疾病发病过程中的相互作用尚不清楚.
- 研究这些分子交叉声对于癌症生物学的进步至关重要.
研究的目的:
- 审查乳酸和RNA修饰之间的调节相互作用的当前知识.
- 探索这种交叉通话在癌症中的功能意义.
- 讨论在癌症治疗中针对这些修改的治疗潜力.
主要方法:
- 对乳化和RNA修饰的现有研究进行文献综述.
- 癌症生物学中的机械参与分析.
- 综合有关治疗策略的信息.
主要成果:
- 乳化和RNA修饰表现出影响癌症进展的复杂交叉声.
- 这种交叉通话的具体机制正开始被阐明.
- 针对这些修改具有新型癌症治疗的潜力.
结论:
- 乳酸和RNA修饰之间的交叉声在癌症中起着重要作用.
- 对这些相互作用的进一步研究可以揭示新的治疗点.
- 联合向策略可能在癌症治疗中提供更高的精度.
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
RNA Stability
33.9K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.9K
Regulation of Expression at Multiple Steps
996
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
996
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


